Abstract
Unstable angina most often results from disruption of an atherosclerotic plaque and a subsequent cascade of pathologic processes that decrease coronary blood flow. Most patients who die during unstable angina do so because of sudden death or an intervening myocardial infarction (MI).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected References
A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study investigators. N Engl J Med. 1998;338:1498–1505.
Anderson HV, Cannon CP, Stone PH, et al. One year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol. 1995;26:1643–1650.
Bar FW, Verheugt FW, Col J, et al. Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome. Results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase. Circulation. 1992;6:131–137.
Boden WE, O’Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med. 1998;338:1785–1792.
Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low-molecular- weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med. 1997;337:447–452.
Distante A, Maseri A, Severi S, et al. Management of vasospastic angina at rest with continuous infusion of isosorbide dinitrate. A double crossover study in a coronary care unit. Am J Cardiol. 1979;44:33–39.
Figueras J, Lidon R, Cortadellas J. Rebound myocardial ischaemia following abrupt interruption of intravenous nitroglycerin infusion in patients with unstable angina at rest. Eur Heart J. 1991;12:5–11.
Gurfinkel EP, Manos EJ, Mejail RI, et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. JAm Coll Cardiol. 1995;26:313–318.
Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial investigators. Platelet Glycoprotein Ilb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med. 1998;339:436–443.
Oler A, Whooley MA, Oler J, Grady D, Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA. 1996;276:811–815.
Parisi AF, Khuri S, Deupree RH, et al. Medical compared with surgical management of unstable angina. 5-year mortality and morbidity in the Veterans Administration Study. Circulation. 1989;80:1176–1189.
White HD, French JK, Norris RM, et al. Effects of streptokinase in patients presenting within 6 hours of prolonged chest pain with ST segment depression.Br Heart J. 1995;73(6):500–505.
Yeghiazarians Y, Braunstein JB, Askari A, Stone PH. Unstable angina pectoris. N Engl J Med. 2000;342:101–114.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Marik, P.E. (2001). Management of the Patient with Unstable Angina/Non-Q-Wave Myocardial Infarction. In: Handbook of Evidence-Based Critical Care. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-86943-3_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-86943-3_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78093-9
Online ISBN: 978-3-642-86943-3
eBook Packages: Springer Book Archive